Navigation Links
Osseon™ Therapeutics Introduces Osseoflex® BT Steerable Bone Tamp
Date:3/29/2011

SANTA ROSA, Calif., March 29, 2011 /PRNewswire/ -- Osseon® Therapeutics announced today at the Society of Interventional Radiology's (SIR) Annual Meeting the launch of the Osseoflex BT Steerable Bone Tamp.  The steerable bone tamp is designed to allow percutaneous access to sclerotic bone.  The Osseoflex BT features the same proprietary technology found in the Osseoflex® Steerable Needle and Osseoflex® DR Steerable Drill.  The Osseoflex BT articulates up to 60 degrees( and, when used in conjunction with the Osseoflex Needle, the Bone Tamp allows unipedicular access to vertebral compression fractures previously considered inaccessible due to dense, sclerotic bone or malignant tissue.  The Bone Tamp also provides clinicians with a percutaneous access option to cancellous bone in other areas of the body.

"The Osseoflex BT is the newest addition to the Osseon suite of steerable, minimally invasive devices," said John Stalcup, Ph.D., Osseon's CEO. "In the coming months, we will continue to develop and introduce complementary innovative products to address physician and patient needs."

Osseon Therapeutics currently markets the Osseoflex Steerable Needle, Osseoperm® Bone Cement, Osseoflex DR Steerable Drill, and Osseoflex Access Kit.  Together, the Osseoplasty Suite represents unparalleled products for physicians involved in the treatment vertebral compression fractures associated with osteoporosis, myelomas, and acute trauma.


'/>"/>
SOURCE Osseon Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Yuma Therapeutics Awarded a Research Grant by the Alzheimers Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimers Disease
2. Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer
3. Reportlinker Adds Therapeutics for Immune System Disorders
4. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
5. Echo Therapeutics Hires Two Seasoned Medical Device and Diagnostics Executives
6. Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting
7. Echo Therapeutics Announces 2010 Financial Results
8. Nile Therapeutics Reports 2010 Fourth Quarter and Full Year Financial Results
9. Reportlinker Adds Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
10. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
11. Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... May 3, 2016 ... dass sie einen entscheidenden Meilenstein durch diese ... Aufruf zum Handeln, um Patientenresultate  bei Verdauungs- ... zu Fortschritten im Verständnis der Hepatischen Enzephalopathie ... Bewusstsein für Hepatische Enzephalopathie in der Öffentlichkeit ...
(Date:5/2/2016)... May 2, 2016  While nearly three-quarters of Americans ... have on their health, only about half report taking ... the results of a new survey announced today by ... start of National Osteoporosis Month, Hologic is raising awareness ... nearly 56 million Americans. Osteoporosis is a ...
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
Breaking Medicine Technology:
(Date:5/4/2016)... Durham, NC (PRWEB) , ... May 04, 2016 ... ... healthcare professionals in medical coding, billing and compliance. In upcoming months, AudioEducator has ... on various specialties. Every conference is designed to give complete compliance know-how and ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... Patient 2016, a powerful cellular therapy software application that helps blood and ... to patients. , Since Transtem’s initial launch, Mediware has continued to enhance core ...
(Date:5/4/2016)... ... ... Fertility Centers of New England announced today the opening of their newest location ... access to care for patients seeking fertility treatment in Maine. “We are delighted to ... Portland,” said Fertility Centers of New England President and CEO, Joseph A. Hill, M.D. ...
(Date:5/3/2016)... , ... May 04, 2016 , ... ... 40 national and global construction firms representing the Construction Industry Safety Initiative (CISI) ... forces with one purpose: to inspire everyone in the industry to be leaders ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... Business Journal, patients report dissatisfaction with numerous issues related to medical care in ... with billing, and poor bedside manner from hospital staff. Commenting on this article, ...
Breaking Medicine News(10 mins):